psychiatry – Page 3 – Retraction Watch

Study errors “may have placed you or your child at a greater risk of harm”: 2014 letter to parents

Three psychiatric studies of children contained a myriad of problems that may have put participants at greater risk than was disclosed by consent forms, according to a 2014 letter sent to hundreds of the participants and their families.

Through a public records request, we’ve obtained a copy of the letter — which lists a host of problems in the studies, ranging from enrolling ineligible patients, not informing families of the risks associated with the studies, and skipping tests intended to minimize the risks associated with lithium.

In 2013, Mani Pavuluri told the University of Illinois at Chicago that one of her study participants had been hospitalized — an event which prompted the university to halt three of her studies, launch a misconduct probe, and send letters to approximately 350 families of children participating in the research, notifying them of what happened.

The letter concludes:

Continue reading Study errors “may have placed you or your child at a greater risk of harm”: 2014 letter to parents

A grad student was caught in the crossfire of fraud — and fought back

In March, 2013, a graduate student joined the lab of a prominent researcher in Australia, investigating new therapies for Parkinson’s. A few months later, everything fell apart.

In September 2013, the University of Queensland (UQ) announced it was retracting one of the lab’s papers, returning the money used to fund the research and launching a fraud investigation. Since then, the scandal has grown to the point where the lead researcher and his co-author have been convicted of fraud in an Australian court.

Now, the graduate student is fighting back. After losing her research project and being escorted off campus for allegedly erratic behavior, she has appealed to UQ to reimburse her for tens of thousands of dollars in tuition, and is now awaiting a verdict from a government ombudsman. The graduate student goes by “Dominique,” which is not her real name; Retraction Watch is keeping her identity confidential to protect her privacy. Continue reading A grad student was caught in the crossfire of fraud — and fought back

Hospitalization of participant in child psych study prompted misconduct inquiry: Letter

The adverse event that prompted the University of Illinois at Chicago to shutter three trials by a child psychiatrist occurred when one of the study subjects was hospitalized.

According to a 2013 letter obtained by Retraction Watch through a public records request, the subject was admitted to a 10-day inpatient treatment program after exhibiting an increase in irritability and aggression, which prompted researcher Mani Pavuluri to notify the university’s Institutional Review Board (IRB) in January of that year. As a result, the university halted three studies by Pavuluri, sent out letters to 350 research subjects, and launched a misconduct inquiry.

Here’s how the document describes the event (with some details blacked out): Continue reading Hospitalization of participant in child psych study prompted misconduct inquiry: Letter

Despite retraction, antipsychotics still effective, safe for dementia, says author

Researchers have retracted a systematic review that suggested that antipsychotic drugs are effective and safe for patients with symptoms of dementia — but claim their re-analysis of the updated data still comes to the same conclusions.

According to the retraction notice in Alzheimer’s Research and Therapy, some participants were incorrectly included twice in the meta-analysis.

The corresponding authors recently lost another paper for an entirely different reason — earlier this year, we reported on a retraction in Annals of Neurology for Jin-Tai Yu and Lan Tan, affiliated with the Ocean University of China, Qingdao University, and Nanjing Medical University in China. The authors pulled that paper after appearing to pass off others’ data as their own.

Here’s the retraction notice for the review, issued earlier this year: Continue reading Despite retraction, antipsychotics still effective, safe for dementia, says author

Child psychiatrist flagged for misconduct loses two more papers

A child psychiatrist has lost two papers after an institutional investigation concluded that she intentionally misrepresented children’s medication history in her research.

In November 2015, we reported on a retraction for Mani Pavuluri in the Journal of Psychiatry & Neuroscience following a probe at the University of Illinois at Chicago, her institution, which concluded that there was a “preponderance of evidence” that Pavuluri had committed misconduct.

After an “unanticipated event” took place during a study, three studies by Pavuluri were halted and a letter was sent out to 350 research subjects, informing them of errors in the work. At the time, the Illinois spokesperson noted that Pavuluri — who, according to her LinkedIn page, is a Distinguished Fellow of the American Academy of Child and Adolescent Psychiatry — was also asked to retract two 2013 studies in the Journal of Affective Disorders. Those papers have now been retracted, noting that Pavuluri “intentionally and knowingly” misrepresented children’s medication history.

Here’s the retraction notice for “Deficits in emotion recognition in pediatric bipolar disorder: The mediating effects of irritability:” Continue reading Child psychiatrist flagged for misconduct loses two more papers

Oh, well — “love hormone” doesn’t reduce psychiatric symptoms, say researchers in request to retract

It turns out, snorting the so-called “love hormone” may not help reduce psychiatric symptoms such as depression and anxiety.

At least, that’s the conclusion the authors of a 2015 meta-analysis, which initially found intranasal doses of oxytocin could reduce psychiatric symptoms, have now reached. After a pair of graduate students pointed out flaws in the paper, the authors realized they’d made some significant errors, and oxytocin shows no more benefit than placebo.

First author Stefan Hofmann from Boston University in Massachusetts explains further in a lengthy letter he sent to Psychiatry Research, which he passed on to us: Continue reading Oh, well — “love hormone” doesn’t reduce psychiatric symptoms, say researchers in request to retract

Authors retract two papers on shock therapy, citing language barriers

An electroconvulsive therapy (ECT) journal has retracted two 2016 papers after uncovering problems in the data analyses, which the author says were due to language barriers.

Interestingly, two authors of the newly retracted papers — Yu-Tao Xiang from the University of Macau in China and Gabor Ungvari from the University of Western Australia — also recently co-authored another paper on an entirely different topic that has received a lengthy correction. That paper — on the use of organs from executed prisoners in China — raised controversy for allegedly reporting a “sanitized” account of the practice. The correction notice, in the Journal of Medical Ethics, was accompanied by a critics’ rebuttal to the paper.

According to Xiang, the newly retracted papers in The Journal of ECT — which examined the efficacy of ECT in treating schizophrenia — were pulled due to “genuine errors” resulting from differences in language. All the authors agree with the retraction, Xiang noted.

Xiang told us: Continue reading Authors retract two papers on shock therapy, citing language barriers

Sting operation forces predatory publisher to pull paper

Sometimes, the best way to expose a problem with the publishing process is to put it to a test — perhaps by performing a Sokal-style hoax, or submitting a paper with obvious flaws.

In 2014, that’s just what a researcher in Kosovo did. Suspicious that a journal wasn’t doing a thorough job of vetting submissions, she decided to send them an article of hers that had already appeared in another journal. Her thinking was that any journal with an honest and thorough peer review process would hesitate to publish the work. But this journal didn’t — at least at first. Though they retracted the paper this summer, it took a few twists and turns to get there.

The researcher wasn’t the only one wary of the journal — it’s on Jeffrey Beall’s list of “potential, possible, or probable” predatory publishers. Appropriately, Beall recounts the story of her sting operation on his blog. Here’s how it all went down:

Continue reading Sting operation forces predatory publisher to pull paper

Is the bulk of fMRI data questionable?

Last week, a study brought into question years of research conducted using the neuroimaging technique functional magnetic resonance imaging (fMRI). The new paper, published in PNAS, particularly raised eyebrows for suggesting that the rates of false positives in studies using fMRI could be up to 70%, which may affect many of the approximately 40,000 studies in academic literature that have so far used the technique. We spoke to the Anders Eklund, from Linköping University in Sweden, who was the first author of the study. Continue reading Is the bulk of fMRI data questionable?

JAMA authors retract (and replace) paper about moves and kids’ mental health

JAMA authors have retracted — and replaced — a 2014 paper about the mental health effects of household moves on kids, after they found errors while completing an additional analysis.

The original paper concluded that in “families who moved out of high-poverty neighborhoods, boys experienced an increase and girls a decrease in rates of depression and conduct disorder,” according to a press release issued by the journal along with the paper (which also got some press attention from Reuters). But part of that conclusion is wrong.

The authors write in a notice for “Associations of Housing Mobility Interventions for Children in High-Poverty Neighborhoods With Subsequent Mental Disorders During Adolescence” that:

Continue reading JAMA authors retract (and replace) paper about moves and kids’ mental health

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: